Dr. Scott A. Kapers, DDS in Saint John, Indiana
-
Aurora Bay Area Prices – INTRODUCER SET APRIMA ACCESS is $400
At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10005488, regarding INTRODUCER SET APRIMA ACCESS, which is classified under revenue code 272 and associated with CPT code C1894, the designated fee stands at $400. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Prenatal Testing and Screenings: What You Need to Know
In conclusion, prenatal testing and screenings are invaluable tools that offer critical insights into the health of both mother and baby. While they provide essential information that can guide medical decisions and prepare parents for potential challenges, it is crucial to approach these tests with a clear understanding of their scope, benefits, and limitations. Consulting with healthcare professionals, considering personal values, and staying informed are key steps in making the best choices for your unique situation. Ultimately, the goal is to ensure the healthiest possible outcomes for both mother and child.
-
Aurora Bay Area Prices – PARAINFLUENZA VIRUS AG, IFA is $75
At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10001619, regarding PARAINFLUENZA VIRUS AG, IFA, which is classified under revenue code 306 and associated with CPT code 87279, the designated fee stands at $75. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
CMS and FDA Launch RAPID Pathway for Breakthrough Devices
CMS and the FDA have created a new Medicare coverage pathway aimed at speeding access to certain breakthrough medical devices. The first practical effect is a faster route to a proposed Medicare coverage decision after FDA authorization, but many details still depend on implementation.
